logo
15:42 Feb 25

Hester Biosciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1559.00
+10.90 (+0.70%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hester Biosciences Ltd. Financials

Hester Biosciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1559.00
+10.90 (+0.70%)
15:42 Feb 25
Quality
image/svg+xml

88/100
High Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

46/100
Technically Neutral

Strength

6

Weakness

2

Opportunity

0

Threats

0

8.74 %

ROE %

4.20 %

ROA %

48.13

EPS

369.41

BVPS

8.83 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
214.33 235.01 266.09 304.55 311.1
Operating Expenses +
145.68 175.03 215.48 250.89 250.06
Raw Material
46.63 73.27 82.74 87.13 81.55
Increase Decrease in Cost
3.6 -10.56 -5.25 8.74 6.78
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
38.92 45.33 56.02 64.13 62.42
Miscellaneous Expenses
72.47 92.23 141.47 156.53 134.51
Operating Profit
68.65 59.98 50.61 53.66 61.04
Other Income
4.68 13.74 15.15 10.64 3.92
Depreciation
13.31 16.58 20.7 17.17 16.8
Interest
6.6 4.06 9.32 19.78 12.7
Profit before tax and exceptio..
53.42 53.08 35.74 27.34 35.47
Exceptional Items
-3.32 0 0 0 0
PBT
50.1 53.08 35.74 27.34 35.47
Provision for Taxation
15.4 14.02 12.12 10.79 10.74
Net Profit
34.7 39.06 23.63 16.56 24.73
NET Profit after MI
34.43 39.48 26.63 18.89 27.49
EPS
40.79 46.41 32.96 24.88 33.89
Operating Profit Margin (%)
32.03 25.52 19.02 17.62 19.62
Net Profit Margin (%)
16.06 16.8 10.01 6.2 8.84

Hester Biosciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 53.70 53.70 53.70 53.70 53.70 53.70
FII 0.50 0.50 0.50 0.90 0.60 0.60
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 45.80 45.80 45.80 45.40 45.70 45.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: